Cosciens Biopharma Files 6-K Report
Ticker: CSCIF · Form: 6-K · Filed: May 30, 2025 · CIK: 1113423
| Field | Detail |
|---|---|
| Company | Cosciens Biopharma INC. (CSCIF) |
| Form Type | 6-K |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, administrative
TL;DR
Cosciens Biopharma (fka Aeterna Zentaris) filed a 6-K, confirming 20-F filings and Canadian HQ.
AI Summary
Cosciens Biopharma Inc. (formerly Aeterna Zentaris Inc.) filed a Form 6-K on May 30, 2025. The filing is a report of a foreign private issuer and indicates the company files annual reports under Form 20-F. The company's principal executive office is located in Toronto, Canada.
Why It Matters
This filing provides routine updates for foreign private issuers, informing investors about the company's reporting status and administrative details.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- COSCIENS Biopharma Inc. (company) — Filer
- Aeterna Zentaris Inc. (company) — Former company name
- AETERNA LABORATORIES INC (company) — Former company name
- Norton Rose Fulbright Canada, LLP (company) — Legal counsel/address provider
- 20250530 (date) — Filing date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to serve as a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 for the month of May 2025.
What is the current name of the company filing this report?
The current name of the company filing this report is COSCIENS Biopharma Inc.
What were the former names of COSCIENS Biopharma Inc.?
The former names of COSCIENS Biopharma Inc. were Aeterna Zentaris Inc. and AETERNA LABORATORIES INC.
Where is the principal executive office of COSCIENS Biopharma Inc. located?
The principal executive office of COSCIENS Biopharma Inc. is located at c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7.
Does the company file annual reports under Form 20-F or Form 40-F?
The registrant (COSCIENS Biopharma Inc.) indicates that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 30, 2025 regarding COSCIENS Biopharma Inc. (CSCIF).